US 10603306
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease
granted A61KA61K31/415A61K9/0053
Quick answer
US patent 10603306 (Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease) held by MEREO BIOPHARMA 1 LIMITED expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MEREO BIOPHARMA 1 LIMITED
- Grant date
- Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/415, A61K9/0053, A61P, A61P11/00